Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers.
作者信息
Welch H Gilbert, Schwartz Lisa M, Woloshin Steven
出版信息
BMJ. 2006 Mar 25;332(7543):727. doi: 10.1136/bmj.332.7543.727.
Abstract
摘要
相似文献
1
Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers.
BMJ. 2006 Mar 25;332(7543):727. doi: 10.1136/bmj.332.7543.727.
2
Ramifications of screening for breast cancer: consent for screening.
BMJ. 2006 Mar 25;332(7543):728. doi: 10.1136/bmj.332.7543.728.
3
Ramifications of screening for breast cancer: definition of overdiagnosis is confusing in follow-up of Malmö trial.
BMJ. 2006 Mar 25;332(7543):727-8. doi: 10.1136/bmj.332.7543.727-b.
4
Ramifications of screening for breast cancer: more debate and better information still needed.
BMJ. 2006 Mar 25;332(7543):728. doi: 10.1136/bmj.332.7543.728-a.
5
Ramifications of screening for breast cancer: overdiagnosis in the Malmö trial was considerably underestimated.
BMJ. 2006 Mar 25;332(7543):727. doi: 10.1136/bmj.332.7543.727-a.
6
Over-diagnosis in breast cancer screening.
BMJ. 2006 Mar 25;332(7543):691-2. doi: 10.1136/bmj.38768.401030.7C. Epub 2006 Mar 3.
7
Screening mammography in women 40 to 49 years of age.
Am Fam Physician. 2004 Nov 1;70(9):1750-2.
8
[The quality of mammography scrutinized. Ongoing control mass screenings for breast cancer is necessary].
Lakartidningen. 1995 Aug 30;92(35):3106-9.
9
[Cancer screening: medico-legal aspects].
Ann Ig. 2003 Jan-Feb;15(1):3-10.
10
Significant reduction in advanced breast cancer. Results of the first seven years of mammography screening in Kopparberg, Sweden.
Diagn Imaging Clin Med. 1985;54(3-4):158-64.
引用本文的文献
1
Patient Preferences for Outcomes Following DCIS Management Strategies: A Discrete Choice Experiment.
JCO Oncol Pract. 2021 Nov;17(11):e1639-e1648. doi: 10.1200/OP.20.00614. Epub 2021 Mar 12.
2
Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancer.
World J Urol. 2022 Jan;40(1):1-8. doi: 10.1007/s00345-020-03523-2. Epub 2021 Jan 25.
3
Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study.
Ann Surg Oncol. 2016 Apr;23(4):1361-70. doi: 10.1245/s10434-015-4986-1. Epub 2015 Nov 23.
4
Clinicopathologic characteristics and molecular subtypes of microinvasive carcinoma of the breast.
Tumour Biol. 2015 Apr;36(4):2241-8. doi: 10.1007/s13277-014-2652-z. Epub 2015 Mar 24.
5
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods.
BMJ. 2015 Jan 7;350:g7773. doi: 10.1136/bmj.g7773.
6
Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis.
Br J Cancer. 2013 Oct 1;109(7):2014-9. doi: 10.1038/bjc.2013.427. Epub 2013 Aug 20.
7
The challenge of conducting comparative effectiveness research in cancer: the impact of a fragmented U.S. health-care system.
J Natl Cancer Inst Monogr. 2013;2013(46):99-105. doi: 10.1093/jncimonographs/lgt008.
8
The benefits and harms of breast cancer screening: an independent review.
Br J Cancer. 2013 Jun 11;108(11):2205-40. doi: 10.1038/bjc.2013.177. Epub 2013 Jun 6.
9
How do I screen patients for breast cancer?
Curr Treat Options Oncol. 2013 Mar;14(1):88-96. doi: 10.1007/s11864-012-0218-0.
10
Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women.
Breast Cancer Res. 2012 Jan 30;14(1):R19. doi: 10.1186/bcr3104.
本文引用的文献
1
Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study.
BMJ. 2006 Mar 25;332(7543):689-92. doi: 10.1136/bmj.38764.572569.7C. Epub 2006 Mar 3.
2
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
BMJ. 1988 Oct 15;297(6654):943-8. doi: 10.1136/bmj.297.6654.943.
Zotero 插件